MicroRNA profiling in chemoresistant and chemosensitive acute myeloid leukemia

Cytogenetic and Genome Research

Volumn 141, Issue 4, 2013, Pages 272-276

  Mosakhani, N ^a   Raty R ^b   Tyybakinoja A ^a   Karjalainen Lindsberg, M L ^a   Elonen, E ^b   Knuutila, S ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

AML; Chemoresistance; MicroRNA

Indexed keywords

CYTARABINE; ETOPOSIDE; GEMTUZUMAB OZOGAMICIN; IDARUBICIN; MICRORNA; MIR 342 3P; MIR 363; MIR 532 5P; MITOXANTRONE; TIOGUANINE; UNCLASSIFIED DRUG; HIPK3 PROTEIN, HUMAN; MIRN342 MICRORNA, HUMAN; MIRN363 MICRORNA, HUMAN; MIRN532 MICRORNA, HUMAN; PROTEIN SERINE THREONINE KINASE; RGS PROTEIN; RGS17 PROTEIN, HUMAN; SIGNAL PEPTIDE; ANTINEOPLASTIC AGENT; IDARUBICINE; MICRORNA 342 3P; MICRORNA 363; MICRORNA 532 5P;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ALLOGENEIC STEM CELL TRANSPLANTATION; ALLOTRANSPLANTATION; ARTICLE; BONE MARROW BIOPSY; CHEMOSENSITIVITY; CLINICAL ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; INDUCTION CHEMOTHERAPY; KARYOTYPE; LEUKEMIA CELL; LEUKEMIA REMISSION; MALE; MICROARRAY ANALYSIS; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TREATMENT RESPONSE; TRISOMY 21; UPREGULATION; BONE MARROW CELL; DNA MICROARRAY; DRUG RESISTANCE; GENE EXPRESSION PROFILING; GENETICS; LEUKEMIA, MYELOID, ACUTE; METABOLISM; MIDDLE AGED; YOUNG ADULT; ACUTE MYELOBLASTIC LEUKEMIA; CANCER DIAGNOSIS; GENE; GENE EXPRESSION; GENE TARGETING; GENETIC ASSOCIATION; HIPK3 GENE; HUMAN TISSUE; RGS17 GENE; VALIDATION STUDY;

ADOLESCENT; ADULT; AGED; BONE MARROW CELLS; DRUG RESISTANCE, NEOPLASM; FEMALE; GENE EXPRESSION PROFILING; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LEUKEMIA, MYELOID, ACUTE; MALE; MICRORNAS; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEIN-SERINE-THREONINE KINASES; RGS PROTEINS; YOUNG ADULT;

EID: 84887127038     PISSN: 14248581     EISSN: 1424859X     Source Type: Journal    
DOI: 10.1159/000351219     Document Type: Article

References (30)

1. Beltran AS, Russo A, Lara H, Fan C, Lizardi PM, Blancafort P: Suppression of breast tumor growth and metastasis by an engineered transcription factor. PLoS One 6:e24595 (2011).
2. Borze I, Guled M, Musse S, Raunio A, Elonen E, et al: MicroRNA microarrays on archive bone marrow core biopsies of leukemias-method validation. Leuk Res 35: 188-195 (2011).
3. Calin GA, Croce CM: MicroRNA signatures in human cancers. Nat Rev Cancer 6: 857-866 (2006). (Pubitemid 44629897)
4. Careccia S, Mainardi S, Pelosi A, Gurtner A, Diverio D, et al: A restricted signature of miRNAs distinguishes APL blasts from normal promyelocytes. Oncogene 28: 4034-4040 (2009).
5. Chatzikyriakidou A, Voulgari PV, Georgiou I, Drosos AA: miRNAs and related polymorphisms in rheumatoid arthritis susceptibility. Autoimmun Rev 11: 636-641 (2012).
6. Choong ML, Yang HH, McNiece I: MicroRNA expression profiling during human cord bloodderived CD34 cell erythropoiesis. Exp Hematol 35: 551-564 (2007). (Pubitemid 46427958)
7. Curtin JF, Cotter TG: JNK regulates HIPK3 expression and promotes resistance to Fas-mediated apoptosis in DU 145 prostate carcinoma cells. J Biol Chem 279: 17090-17100 (2004). (Pubitemid 38560465)
8. Derolf AR, Kristinsson SY, Andersson TM, Landgren O, Dickman PW, Björkholm M: Improved patient survival for acute myeloid leukemia: a population-based study of 9729 patients diagnosed in Sweden between 1973 and 2005. Blood 113: 3666-3672 (2009).
9. Esquela-Kerscher A, Slack FJ: Oncomirs-micro-RNAs with a role in cancer. Nat Rev Cancer 6: 259-269 (2006).
10. Estey E, Döhner H: Acute myeloid leukaemia. Lancet 368: 1894-1907 (2006). (Pubitemid 44794525)
11. Garzon R, Pichiorri F, Palumbo T, Visentini M, Aqeilan R, et al: MicroRNA gene expression during retinoic acid-induced differentiation of human acute promyelocytic leukemia. Oncogene 26: 4148-4157 (2007). (Pubitemid 46920170)
12. Guglielmelli P, Tozzi L, Pancrazzi A, Bogani C, Antonioli E, et al: MicroRNA expression profile in granulocytes from primary myelofibrosis patients. Exp Hematol 35: 1708-1718 (2007).
13. Hooks SB, Callihan P, Altman MK, Hurst JH, Ali MW, Murph MM: Regulators of G-Protein signaling RGS10 and RGS17 regulate chemoresistance in ovarian cancer cells. Mol Cancer 9: 289 (2010).
14. Hsu YC, Yuan S, Chen HY, Yu SL, Liu CH, et al: A four-gene signature from NCI-60 cell line for survival prediction in non-small cell lung cancer. Clin Cancer Res 15: 7309-7315 (2009).
15. Humbert M, Halter V, Shan D, Laedrach J, Leibundgut EO, et al: Deregulated expression of Kruppel-like factors in acute myeloid leukemia. Leuk Res 35: 909-913 (2011).
16. Kitago M, Martinez SR, Nakamura T, Sim MS, Hoon DS: Regulation of RUNX3 tumor suppressor gene expression in cutaneous melanoma. Clin Cancer Res 15: 2988-2994 (2009).
17. Li J, Smyth P, Flavin R, Cahill S, Denning K, et al: Comparison of miRNA expression patterns using total RNA extracted from matched samples of formalin-fixed paraffin-embedded (FFPE) cells and snap frozen cells. BMC Biotechnol 7: 36 (2007).
18. Li S, Moffett HF, Lu J, Werner L, Zhang H, et al: MicroRNA expression profiling identifies activated B cell status in chronic lymphocytic leukemia cells. PLoS One 6:e16956 (2011).
19. Li Z, Huang H, Li Y, Jiang X, Chen P, et al: Upregulation of a HOXA-PBX3 homeobox-gene signature following down-regulation of miR-181 is associated with adverse prognosis in patients with cytogenetically abnormal AML. Blood 119: 2314-2324 (2012).
20. Marcucci G, Radmacher MD, Maharry K, Mrózek K, Ruppert AS, et al: MicroRNA expression in cytogenetically normal acute myeloid leukemia. N Engl J Med 358: 1919-1928 (2008). (Pubitemid 351620112)
21. Mosakhani N, Guled M, Lahti L, Borze I, Forsman M, et al: Unique microRNA profile in Dupuytren's contracture supports deregulation of ?-catenin pathway. Mod Pathol 23: 1544-1552 (2010).
22. Mosakhani N, Sarhadi VK, Usvasalo A, Karjalainen-Lindsberg ML, Lahti L, et al: MicroRNA profiling in pediatric acute lymphoblastic leukemia: novel prognostic tools. Leuk Lymphoma 53: 2517-2520 (2012).
23. Nymark P, Guled M, Borze I, Faisal A, Lahti L, et al: Integrative analysis of microRNA, mRNA and aCGH data reveals asbestos-and histology-related changes in lung cancer. Genes Chromosomes Cancer 50: 585-597 (2011).
24. Ronchetti D, Lionetti M, Mosca L, Agnelli L, Andronache A, et al: An integrative genomic approach reveals coordinated expression of intronic miR-335, miR-342, and miR-561 with deregulated host genes in multiple myeloma. BMC Med Genomics 1: 37 (2008).
25. Rukov JL, Shomron N: MicroRNA pharmacogenomics: post-transcriptional regulation of drug response. Trends Mol Med 17: 412-423 (2011).
26. Setoyama T, Ling H, Natsugoe S, Calin GA: Noncoding RNAs for medical practice in oncology. Keio J Med 60: 106-113 (2011).
27. Shell S, Park SM, Radjabi AR, Schickel R, Kistner EO, et al: Let-7 expression defines two differentiation stages of cancer. Proc Natl Acad Sci USA 104: 11400-11405 (2007). (Pubitemid 47175152)
28. Wald AI, Hoskins EE, Wells SI, Ferris RL, Khan SA: Alteration of microRNA profiles in squamous cell carcinoma of the head and neck cell lines by human papillomavirus. Head Neck 33: 504-512 (2011).
29. Zhu DX, Miao KR, Zhu YD, Zhu HY, Fan L, et al: Detection of miRNA levels in leukemia patients by real-time quantitative PCR (in Chinese). Zhongguo Shi Yan Xue Ye Xue Za Zhi 18: 757-761 (2010).
30. Zhu YD, Wang L, Sun C, Fan L, Zhu DX, et al: Distinctive microRNA signature is associated with the diagnosis and prognosis of acute leukemia. Med Oncol 29: 2323-2331 (2012).